Literature DB >> 19562680

Transport characteristics of candesartan in human intestinal Caco-2 cell line.

Lingjie Zhou1, Xiaoping Chen, Yuanqing Gu, Jianying Liang.   

Abstract

The intestinal absorptive characteristics and the efflux mechanisms of candesartan (CDS), a novel angiotensin II type 1 receptor blocker, were investigated. The Caco-2 cells were used as models of the intestinal mucosa to assess uptake and transport of CDS. The determination of CDS was performed by HPLC-Flu. In the Caco-2 cells, the uptake and absorptive transport of CDS were pH-independent (in the pH range 6.0-8.0). Passive membrane diffusion dominates the absorptive transport behavior of CDS across Caco-2 cells, while secretory transport was a concentration-dependent and saturable process. In the presence of cyclosporin A and verapamil, potent inhibitors of P-glycoprotein (P-gp), the P(ratio) decreased from 3.8 to 2.3 and 1.8, respectively, and permeation of apical to basolateral was enhanced. Overall, the current study suggests that efflux transporters are capable of mediating the absorption and secretion of CDS, and they may play significant roles in limiting the oral absorption of CDS. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562680     DOI: 10.1002/bdd.664

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  5 in total

1.  Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs.

Authors:  S Gurunath; Baswaraj K Nanjwade; P A Patila
Journal:  Saudi Pharm J       Date:  2013-04-08       Impact factor: 4.330

2.  Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System.

Authors:  Ayman F El-Kattan; Manthena V Varma; Stefan J Steyn; Dennis O Scott; Tristan S Maurer; Arthur Bergman
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

3.  Predicting when biliary excretion of parent drug is a major route of elimination in humans.

Authors:  Chelsea M Hosey; Fabio Broccatelli; Leslie Z Benet
Journal:  AAPS J       Date:  2014-07-09       Impact factor: 4.009

4.  No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects.

Authors:  Jung-Ryul Kim; Seokuee Kim; Wooseong Huh; Jae-Wook Ko
Journal:  Drug Des Devel Ther       Date:  2018-08-10       Impact factor: 4.162

5.  A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Cells       Date:  2019-10-21       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.